Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-24-000078
Filing Date
2024-11-08
Accepted
2024-11-08 16:01:40
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20240930.htm   iXBRL 10-Q 1454447
2 EX-10.2 exhibit102-severanceagreem.htm EX-10.2 54388
3 EX-31.1 lgnd_93024exhibit311.htm EX-31.1 15161
4 EX-31.2 lgnd_93024exhibit312.htm EX-31.2 15431
5 EX-32.1 lgnd_93024exhibit321.htm EX-32.1 11172
11 image_0a.jpg GRAPHIC 124
12 lgnd-20240930_g1.jpg GRAPHIC 43732
  Complete submission text file 0000886163-24-000078.txt   9461981

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20240930.xsd EX-101.SCH 65654
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20240930_cal.xml EX-101.CAL 112338
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20240930_def.xml EX-101.DEF 441256
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20240930_lab.xml EX-101.LAB 879180
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20240930_pre.xml EX-101.PRE 638315
80 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20240930_htm.xml XML 1277581
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 241440381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)